gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · TLRYHealthcarePharmaceuticals

Tilray Brands, Inc. Common Stock (TLRY)

$2.96+11.70%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$2.96▼ 76.13% in range
Earnings Oct 8, 2026Earnings Jul 28, 2026Earnings Jul 27, 2026Earnings Apr 14, 2026Earnings Apr 1, 2026
Nov 4, 2025Low $2.53 · High $13.94Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Tilray Brands closed at $2.96 on Nov 4, up 11.70%, 78.8% below its 52-week closing high. Volume of 12.7M shares was 2.86× its 20-day average (well above normal).

Split-adjusted performance: -21.7% over one month, -48.6% over six months, -77.4% over one year.

In the quarter ended Aug 31, 2026, revenue was $257.15M, up 22.7% from a year earlier, with a net margin of -16.8%.

Short interest was 21.5M shares at the Oct 15 settlement, up 14.5% from the prior report (14.6% of float, 4.5 days to cover).

After its Oct 8 report (EPS missed estimates by 76.4%), the stock moved -4.7% from the close before to the close after.

Market cap$437.5M147.8M shares
Revenue · quarter$257.1M+22.7% YoY
Diluted EPS$-0.32—
P/E · TTM—P/S 0.5×
Net margin-16.8%Gross 30.1%
Dividend yieldNone
52-week range2.53 – 13.94−78.8% from high
Volume12.7M2.86× 20-day avg
Volatility · 60d50.2%Annualised
Short % of float14.6%4.5 days to cover
Net cash$16.6MCash $218.0M
Next earnings—Not scheduled
Split-adjusted performance
1W +10.0%1M −21.7%3M −33.3%6M −48.6%YTD −67.2%1Y −77.4%3Y −82.9%5Y −97.1%

Earnings reactions

History →
Oct 8−4.7%
Jul 28−1.0%
Jul 27+3.9%
Apr 14+3.4%
Apr 1+1.2%

Close before the report to close after it.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum27
Revenue growth68
Net margin59
Value (low P/E)—
Size59

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →
Shares short21.5M+14.5% vs prior
Days to cover4.5Settled Oct 15
% of float14.6%
Short vol. 10d51.5%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
TLRYTilray Brands$2.96+11.70%−48.6%+22.7%−16.8%—$437.5M
INDPIndaptus Therapeutics$3.30+1.85%+61.0%———$439.7MCompare
CRMDCorMedix$5.66+1.80%−29.7%+156.5%25.5%2.4$441.2MCompare
PRTAProthena$8.39+2.19%−25.0%−77.1%−1839.9%—$430.7MCompare
RLMDRelmada Therapeutics$4.17−2.34%−46.9%———$444.8MCompare
PHATPhathom Pharmaceuticals$5.68−1.05%−55.2%+71.1%−16.4%—$461.7MCompare
ALTAltimmune$2.12+3.92%−35.0%−100.0%——$412.4MCompare
GYREGyre Therapeutics$4.440.00%−44.8%−2.1%−40.1%—$470.8MCompare
ASMBAssembly Biosciences$19.87−0.25%−36.6%+38.9%−28.8%—$404.6MCompare

News about Tilray Brands

All news →
Forget U.S. Rescheduling: Tilray's 71% Growth in Europe Is the Story Investors Are MissingThe Motley Fool · 3d ago▲ PositiveCanopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in CannabisThe Motley Fool · 5d ago▲ PositiveDown 70% in 2026, Has Tilray's Stock Finally Bottomed Out?The Motley Fool · Oct 27, 2026▼ NegativeTilray Now Sells More Beer Than Cannabis. Here's Why That Might Be Good News for Investors.The Motley Fool · Oct 25, 2026NeutralCanopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?The Motley Fool · Oct 15, 2026▲ Positive

Quick answers

What does Tilray Brands do?
Tilray is a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball.
What is TLRY's market cap?
$437.45M, based on the Nov 4 close of $2.96.
Does Tilray Brands pay a dividend?
No regular cash dividend has been paid in the last year.
How much of TLRY is sold short?
21.5M shares, 14.6% of float, as of Oct 15, 2026.
What sector is TLRY in?
Healthcare, in the Pharmaceuticals industry.

About Tilray Brands

Tilray is a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.

HQ: New York, NY3,595 employeesListed Jan 23, 2015tilray.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology